362 filings
Page 16 of 19
8-K
z0dosrle jh
14 Nov 08
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ea5wt41mrdv5uxjp5w24
6 Nov 08
Entry into a Material Definitive Agreement
12:00am
8-K
fo9ez83cy
3 Nov 08
Dynavax Announces Third Quarter 2008 Financial Results
12:00am
8-K
6kliixm9
22 Oct 08
Other Events
12:00am
8-K
2he012mhd5r3
8 Oct 08
Departure of Directors or Principal Officers
12:00am
8-K
odrviqfqkx 2px3uszp6
29 Sep 08
Dynavax Awarded $17 Million Contract from
12:00am
8-K
or6hv opq
24 Sep 08
Dynavax Receives Milestone from Astrazeneca
12:00am
8-K
wwmstxyt zs
18 Sep 08
Other Events
12:00am
8-K
erqeg7 58c91x9
28 Aug 08
Termination of a Material Definitive Agreement
12:00am
8-K
8i2 lgd1prbz1t
6 Aug 08
Dynavax Announces Second Quarter 2008 Financial Results
12:00am
8-K
2e1et
5 Jun 08
Other Events
12:00am
8-K
5k2tsi
20 May 08
Company Updates 2008 Financial Outlook
12:00am
8-K
fynmqi3
30 Apr 08
Dynavax Announces First Quarter 2008 Financial Results
12:00am
8-K
06qjr ft37
22 Feb 08
Dynavax Announces Fourth Quarter and Year-end 2007 Financial Results and Provides 2008 Financial Outlook
12:00am
8-K
cziozu84p
22 Feb 08
Entry into a Material Definitive Agreement
12:00am
8-K
vqjuvugy mqddbm7
12 Feb 08
Departure of Directors or Principal Officers
12:00am
8-K
2sbr 1t24xrp9u
7 Nov 07
DYNAVAX and MERCK & CO., INC. ANNOUNCE PARTNERSHIP TO DEVELOP HEPLISAV™, AN INVESTIGATIONAL HEPATITIS B VACCINE CURRENTLY IN PHASE 3
12:00am
8-K
jaekdlx9 x7w1nc
1 Nov 07
Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook
12:00am
8-K
9xpuyrs0bwobsy63
2 Aug 07
Dynavax Announces Second Quarter 2007 Financial Results
12:00am
8-K
zdedxdcu x4odr03
24 Jul 07
Entry into a Material Definitive Agreement
12:00am